Manufacturing of high quality cell and gene therapy products

SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.

We will attend to ISCT 2024

May 29 – April 1, 2024 in Vancouver

We will attend to German Biotech Days

April 16 - April 17, 2024 in Berlin

We will attend to EMBT global conference

April 14- April 17, 2024 in Glasgow

We will attend to Cell & gene on the Med

April 09 - April 11, 2024 in Roma

SCTbio Brochure

SCTbio Your Reliable Partner for Cell & Gene Therapy GMP Manufacturing

SCTbio Brochure for Analytical Services

Check-out SCTbio full range of analytical capabilities!

Certificate of GMP Compliance

CIR Certification from the Government of France

Validation and Comparability of the BACTEC method & BD FX40 Device for Sterility Testing of CAR-T Drug Products: A Comprehensive Study

We will attend to Advanced Therapies Congress

March 19-20, 2024 in London

Validating BD BACTEC FX40 Method for CAR-T Sterility Testing

We attended BIO-EUROPE FALL

November 6 - November 8, 2023 in Munich Germany

We attended ESGCT 30th ANNUAL CONGRESS

October 24 - October 27, 2023 in Brussels, Belgium

SCTbio and Cyto-care Collaborate to Improve Cell Therapy Cryopreservation and Logistics Capabilities in Europe

Source: Press Release - Prague, Czech Republic and Vienna, Austria

Orgenesis Announces Collaboration Agreement with SCTbio for the Production of Lentivirus Vectors

Source: Press Release - Germantown, MD and Prague, Czech Republic

We attended ISCT

May 31- June 3, 2023 in Paris, France

We attended The American Society of Gene & Cell Therapy (ASGCT)

May 16-20iest, 2023 in Los Angeles, California, USA

We attended Cell & Gene Meeting on the Med

April 12-14th, 2023 in Barcelona, Spain

We attended 10th Gene Quantification Event

March 20-24th, 2023 in Weihenstephan, Germany

We attended Advanced Therapies Congress

March 14-15th, 2023 in London, UK

We attended the CAR-TCR Europe

February 21-23rd, 2023 in London, UK

We attended the Viral Vector Process Development Summit

January 31- February 2nd, 2023 in Boston, MA, US

We attended the Advanced Therapies Week

January 17-23rd, 2023 in Miami, Florida, US

We attended to Cell & Gene Therapy Manufacturing & Commercialization Europe 2022

December 6-8th, 2022 in Amsterdam, NL

We attended to 3rd CELL & GENE ROUNDTABLE "X-CELLERATOR"

October 20th, 2022 in Berlin, Germany

We attended to Cell & Gene on the Mesa

October 11-13th, 2022 in Carlsbad, CA

We attended to Nordic Life Sciences Days

September 28-29th, 2022 in Malmo, Sweden

We attended to 6th International Symposium on CAR T cells (CAR T Day)

September 7-9th, 2022 in Lille, France

We attended to Advanced Therapies Europe

August 31st - September 1st, 2022 in London, UK 

We attended the Advanced Therapies 2022 Congress

May 24-25, 2022 in London, UK

We attended the ASGCT 25th Annual Meeting

May 16-19, 2022 in Washington, D.C.

SCTbio Video

Take a tour of our GMP manufacturing facility in Prague.

Change of company name: SOTIO a.s. is now SCTbio a.s.

Company split

Ukázka článku - Media

Praesent nec arcu lorem. Nulla vitae malesuada nisl, nec laoreet enim. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Cambridge

SOTIO, LLC
200 Cambridgepark Drive, Suite 3100,
Cambridge, MA 02140
USA

Prague

SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic

Bejing

SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic

Manufacturing of high quality cell and gene therapy products

SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.

Manufacturing of high quality cell and gene therapy products

SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.

Leading engine
for the field of cell
and gene therapy

SCTbio is a stand-alone contract manufacturing organization offering full GMP services covering production of Advanced Therapy Medicinal Products (ATMPs) including genetically modified and viral vectors.  It is a part of PPF Biotech network. The  SCTbio mission is to serve as the leading engine for the rapidly advancing field of cell and gene therapy by offering a superior approach to GMP manufacturing for its partners. 

Services


SCTbio offers its capacities in the GMP manufacturing facility in Prague. The SCTbio expert team is available to manage technology transfers of products in any stage of preclinical/clinical development and to accommodate it to high cGMP standards.

Cell and gene therapy researchers working in SCTbio’s GMP laboratory.
Lab technician working at a microplate reader in SCTbio’s cell and gene facility.
Lab employees in full personal protective equipment handling cell and gene therapy products.
Employee loading up a cardboard box of biologic samples at SCTbio’s contract manufacturing facility.
Cell and gene therapy samples in a box.
Calculator and office equipment on some paper at SCTbio offices in Prague.

Facilities


SCTbio is proud to be a global organization, operating facilities in two continents which include GMP cell therapy manufacturing facilities in Prague, Czech Republic and Beijing, China. SCTbio has also access to a viral vector manufacturing facility operated by its affiliated company based in Cambridge, MA, USA.  

Cambridge

SOTIO, LLC
200 Cambridgepark Drive, Suite 3100,
Cambridge, MA 02140
USA

Prague

SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic

Bejing

Manufacturing Facility SCTbio
Beijing Economic-Technological Dev. Area,
99 Kechuang 14, 30-B,
Beijing 100176, China